Pathophysiology of the brain extracellular matrix: a new target for remyelination
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Pathophysiology of the brain extracellular matrix: a new target for remyelination
Authors
Keywords
-
Journal
NATURE REVIEWS NEUROSCIENCE
Volume 14, Issue 10, Pages 722-729
Publisher
Springer Nature
Online
2013-08-29
DOI
10.1038/nrn3550
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Fibronectin aggregation in multiple sclerosis lesions impairs remyelination
- (2013) Josephine M. J. Stoffels et al. BRAIN
- Chondroitin sulfate proteoglycans inhibit oligodendrocyte myelination through PTPσ
- (2013) James C. Pendleton et al. EXPERIMENTAL NEUROLOGY
- Chondroitin sulfate proteoglycans in demyelinated lesions impair remyelination
- (2012) Lorraine W. Lau et al. ANNALS OF NEUROLOGY
- Cortical remyelination: A new target for repair therapies in multiple sclerosis
- (2012) Ansi Chang et al. ANNALS OF NEUROLOGY
- Digestion products of the PH20 hyaluronidase inhibit remyelination
- (2012) Marnie Preston et al. ANNALS OF NEUROLOGY
- Scar-mediated inhibition and CSPG receptors in the CNS
- (2012) Kartavya Sharma et al. EXPERIMENTAL NEUROLOGY
- Laminin regulates postnatal oligodendrocyte production by promoting oligodendrocyte progenitor survival in the subventricular zone
- (2012) Jenne Relucio et al. GLIA
- The endogenous proteoglycan-degrading enzyme ADAMTS-4 promotes functional recovery after spinal cord injury
- (2012) Ryoji Tauchi et al. Journal of Neuroinflammation
- Developing inhibitors of glycan processing enzymes as tools for enabling glycobiology
- (2012) Tracey M Gloster et al. Nature Chemical Biology
- NgR1 and NgR3 are receptors for chondroitin sulfate proteoglycans
- (2012) Travis L Dickendesher et al. NATURE NEUROSCIENCE
- The perineuronal net component of the extracellular matrix in plasticity and epilepsy
- (2012) Paulette A. McRae et al. NEUROCHEMISTRY INTERNATIONAL
- Chondroitinase and Growth Factors Enhance Activation and Oligodendrocyte Differentiation of Endogenous Neural Precursor Cells after Spinal Cord Injury
- (2012) Soheila Karimi-Abdolrezaee et al. PLoS One
- A sulfated carbohydrate epitope inhibits axon regeneration after injury
- (2012) J. M. Brown et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Extracellular matrix and perineuronal nets in CNS repair
- (2011) Jessica C.F. Kwok et al. Developmental Neurobiology
- Chondroitinase treatment following spinal contusion injury increases migration of oligodendrocyte progenitor cells
- (2011) Justin R. Siebert et al. EXPERIMENTAL NEUROLOGY
- Targeted downregulation of N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase significantly mitigates chondroitin sulfate proteoglycan-mediated inhibition
- (2011) Lohitash Karumbaiah et al. GLIA
- The inhibitory effects of chondroitin sulfate proteoglycans on oligodendrocytes
- (2011) Justin R. Siebert et al. JOURNAL OF NEUROCHEMISTRY
- Reduced inflammation accompanies diminished myelin damage and repair in the NG2 null mouse spinal cord
- (2011) Karolina Kucharova et al. Journal of Neuroinflammation
- Integrin Activation Promotes Axon Growth on Inhibitory Chondroitin Sulfate Proteoglycans by Enhancing Integrin Signaling
- (2011) C. L. Tan et al. JOURNAL OF NEUROSCIENCE
- Leukocyte Common Antigen-Related Phosphatase Is a Functional Receptor for Chondroitin Sulfate Proteoglycan Axon Growth Inhibitors
- (2011) D. Fisher et al. JOURNAL OF NEUROSCIENCE
- 6-Sulphated Chondroitins Have a Positive Influence on Axonal Regeneration
- (2011) Rachel Lin et al. PLoS One
- Expression and Effects of Hyaluronan and of the Hyaluronan-Binding Protein Hyaluronectin in Newborn Rat Brain Glial Cell Cultures
- (2010) Stéphane Marret et al. JOURNAL OF NEUROCHEMISTRY
- Bral1: Its Role in Diffusion Barrier Formation and Conduction Velocity in the CNS
- (2010) Y. Bekku et al. JOURNAL OF NEUROSCIENCE
- Reactive astrocytes as therapeutic targets for CNS disorders
- (2010) Mary E. Hamby et al. Neurotherapeutics
- Matrix metalloproteinases: What do they not do? New substrates and biological roles identified by murine models and proteomics
- (2009) David Rodríguez et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Actomyosin contractility controls cell surface area of oligodendrocytes
- (2009) Angelika Kippert et al. BMC CELL BIOLOGY
- A Disintegrin-like and Metalloprotease (Reprolysin-type) with Thrombospondin Type 1 Motif (ADAMTS) Superfamily: Functions and Mechanisms
- (2009) Suneel S. Apte JOURNAL OF BIOLOGICAL CHEMISTRY
- Fibronectin attenuates process outgrowth in oligodendrocytes by mislocalizing MMP-9 activity
- (2009) Zuzana Šišková et al. MOLECULAR AND CELLULAR NEUROSCIENCE
- Carcinoma-produced factors activate myeloid cells through TLR2 to stimulate metastasis
- (2009) Sunhwa Kim et al. NATURE
- PTP Is a Receptor for Chondroitin Sulfate Proteoglycan, an Inhibitor of Neural Regeneration
- (2009) Y. Shen et al. SCIENCE
- Differentiation block of oligodendroglial progenitor cells as a cause for remyelination failure in chronic multiple sclerosis
- (2008) T. Kuhlmann et al. BRAIN
- Elevated Matrix Metalloproteinase-9 and Degradation of Perineuronal Nets in Cerebrocortical Multiple Sclerosis Plaques
- (2008) Elizabeth Gray et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- Two Faces of Chondroitin Sulfate Proteoglycan in Spinal Cord Repair: A Role in Microglia/Macrophage Activation
- (2008) Asya Rolls et al. PLOS MEDICINE
- CNS injury, glial scars, and inflammation: Inhibitory extracellular matrices and regeneration failure
- (2007) Michael T. Fitch et al. EXPERIMENTAL NEUROLOGY
- A ‘GAG’ reflex prevents repair of the damaged CNS
- (2007) Larry S. Sherman et al. TRENDS IN NEUROSCIENCES
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More